YAP-TEAD PROTAC（Beactica ）

N/A

Report date: 2023/03/02 17:54:32
NME

Base Information

Drug NameYAP-TEAD PROTAC（Beactica ）
Drug Alias NameN/A
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionTranscriptional enhancer factor inhibitorsTranscriptional coactivator YAP1 inhibitors
TargetsTranscriptional enhancer factorTranscriptional coactivator YAP1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBeactica Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesNational Center For Advancing Translational SciencesBeactica Therapeutics AB
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A